Premium
Letter: metformin reduces the risk of hepatocellular carcinoma in diabetic patients. Authors' reply
Author(s) -
VilarGomez Eduardo,
Chalasani Naga
Publication year - 2019
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.15486
Subject(s) - medicine , metformin , hepatocellular carcinoma , diabetes mellitus , carcinoma , oncology , gastroenterology , endocrinology